Royce & Associates LP Standard Biotools Inc. Transaction History
Royce & Associates LP
- $10.5 Billion
- Q3 2024
A detailed history of Royce & Associates LP transactions in Standard Biotools Inc. stock. As of the latest transaction made, Royce & Associates LP holds 614,552 shares of LAB stock, worth $1.02 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
614,552
Previous 304,231
102.0%
Holding current value
$1.02 Million
Previous $538,000
120.45%
% of portfolio
0.01%
Previous 0.01%
Shares
6 transactions
Others Institutions Holding LAB
# of Institutions
143Shares Held
279MCall Options Held
27.2KPut Options Held
34.1K-
Casdin Capital, LLC New York, NY71.3MShares$118 Million10.68% of portfolio
-
Viking Global Investors LP58.7MShares$97.4 Million0.44% of portfolio
-
Black Rock Inc. New York, NY21.8MShares$36.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA17.3MShares$28.7 Million0.0% of portfolio
-
Morgan Stanley New York, NY15.2MShares$25.3 Million0.0% of portfolio
About STANDARD BIOTOOLS INC.
- Ticker LAB
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 78,654,800
- Market Cap $131M
- Description
- Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems, Hyperion tissue imagers, and flow conductors; and assays and reagents, including Maxpar ...